Chen J, Yu N, Li H, Tang Y, Zhu H. Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo.
J Int Med Res 2022;
50:3000605221119646. [PMID:
36062405 PMCID:
PMC9446466 DOI:
10.1177/03000605221119646]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Objective
Platelet-rich plasma (PRP) is a novel treatment option for vitiligo. PRP has
been reported to be effective in combination with 308-nm excimer laser
therapy, but there is no consensus on their combination use. Therefore, this
meta-analysis assessed the efficacy and safety of the combination regimen in
patients with vitiligo compared with laser therapy alone.
Methods
The meta-analysis was performed by searching PubMed, EMBASE, Web of Science,
Cochrane Library, Chinese National Knowledge Infrastructure, and WanFang to
identify relevant publications published through 1 February 2022.
Results
Six studies involving 302 patients were included. Compared with phototherapy
alone, combination treatment with PRP and 308-nm excimer laser therapy
significantly improved the total response rate and reduced the no response
rate. Additionally, the proportions of patients with repigmentation rates of
≥75%, ≥50%, and ≥25% were significantly higher in the combination group than
in the monotherapy group. In addition, the rates of adverse events for
combination therapy were comparable to those for laser therapy alone, and
the recurrence rates were low.
Conclusions
This meta-analysis provided evidence supporting the combined use of PRP and
308-nm excimer laser therapy as a valuable treatment modality for patients
with vitiligo based on its superiority to monotherapy.
Collapse